Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate that the Diagnostic Absorbent Panty liner (AL-SENSE Amniotic Leak Test Kit), developed by Common Sense Ltd., can distinguish between wetness sensed by pregnant women that is caused by amniotic fluid leakage and that which is caused by urinary incontinence.


Clinical Trial Description

n/a


Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT00604838
Study type Interventional
Source Western Galilee Hospital-Nahariya
Contact
Status Completed
Phase Phase 1/Phase 2
Start date May 2006
Completion date November 2006

See also
  Status Clinical Trial Phase
Recruiting NCT04963465 - The Accuracy of Amniotic Fluid Ferning in the Second Trimester in the Diagnosis of Preterm Prelabor Rupture of Membranes
Completed NCT04100252 - The Impact of Amniotic Fluid Index (AFI) on Maternal and Perinatal Outcomes in Pregnant Women With Preterm Premature Rupture of Membranes
Completed NCT03190434 - Pivotal Study of the AL-SENSE in Diagnosis Amniotic Fluid Leakage N/A
Active, not recruiting NCT01517633 - Study of a Diagnostic Device for Identifying Between Amniotic Fluid to Urine Phase 2/Phase 3